Concepedia

Elizabeth Round

ER

Statistics

Publications

13

Citations

1K

H-Index

12

Active since

1984

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Elizabeth Round is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and diabetes mellitus.

Publications per year

1984–2017

13

Publications

13

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Debora Williams‐Herman, Samuel S. Engel, Elizabeth Round et al. · BMC Endocrine Disorders · 2010 · 255 citations · Full text

, , +14

Finasteride in the treatment of men with frontal male pattern hair loss

James L. Leyden, Frank Dunlap, Bruce Miller et al. · Journal of the American Academy of Dermatology · 1999 · 244 citations

, , +6

Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis

Debora Williams‐Herman, Elizabeth Round, Arlene S. Swern et al. · BMC Endocrine Disorders · 2008 · 130 citations · Full text

, , +17

Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies

Samuel S. Engel, Elizabeth Round, Gregory T. Golm et al. · Diabetes Therapy · 2013 · 122 citations · Full text

, , +12

Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo

Elise A. Olsen, David A. Whiting, R Savin et al. · Journal of the American Academy of Dermatology · 2012 · 46 citations

, , +8

1–5 of 13